Protocol Ledger

NCT06991257 · Phase II · RECRUITING

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Interventional Phase II clinical trial protocol NCT06991257 sponsored by Pfizer in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-06-19 Enrollment: 620 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06991257
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)620 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06991257
Protocol FieldVerified Registry Value
NCT IdentifierNCT06991257
Consolidated Lead SponsorPfizer
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment620 participants (ESTIMATED)
Registered Start Date2025-06-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06991257
Hospital Research SiteLocationSite Profile
Jacksonville Center for Clinical ResearchJacksonville, FLOpen Hospital Dossier ->
Northwestern Memorial and Lurie Cancer CenterChicago, ILOpen Hospital Dossier ->

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Pfizer across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI